Table 5:
Percent of participants with sustained plasma HIV RNA suppression by genotype.
| Gene | Genetic variant | % suppressed |
|---|---|---|
| ABCG2 | C/C | 16/43 (37.21%) |
| A/A or C/A | 2/10 (20.00%) | |
| NR1I2 | C/C | 7/20 (35.00%) |
| T/T or C/T | 11/33 (33.33%) | |
| UGT1A1 (Model 1) | Normal | 11/36 (30.56%) |
| Intermediate | 5/13 (38.46%) | |
| Poor | 2/4 (50.00%) | |
| UGT1A1 (Model 2) | Normal/Intermediate | 16/49 (32.65%) |
| Poor | 2/4 (50.00%) |